ArticlePDF Available

Off-pump versus on-pump coronary artery bypass grafting: comparative effectiveness

Authors:

Abstract and Figures

Shahzad G Raja Department of Cardiac Surgery, Harefield Hospital, London, UK Background: Historically, coronary artery bypass grafting (CABG) with the use of cardiopulmonary bypass (CPB), referred to as on-pump CABG, has been regarded as the “gold standard”. However, in recent years, it has been increasingly recognized that the systemic inflammatory response associated with using CPB contributes substantially to postoperative organ dysfunction. Intuitively, performance of CABG without CPB, referred to as off-pump CABG, should translate into improved clinical outcomes. Interestingly, no single randomized trial has been able to prove the superiority of off-pump CABG over on-pump CABG for all hard outcomes, and off-pump CABG remains the subject of intense scrutiny as well as controversy. The purpose of the review is to summarize the current best available evidence, comparing the effectiveness of off- and on-pump CABG. Methods: The English language scientific literature was reviewed primarily by searching MEDLINE from January 2010 to December 2014 using PubMed interface to identify meta-analyses and systematic reviews of randomized controlled trials as well as observational studies using propensity score matching, comparing the effectiveness of off- and on-pump CABG. Results: Current best available evidence from meta-analyses and systematic reviews of randomized controlled trials as well as propensity score analyses suggests that off-pump CABG is associated with fewer distal anastomoses, increased repeat revascularization rates, and poor saphenous vein graft patency compared with on-pump CABG. No significant differences were observed for other hard outcomes including mortality, myocardial infarction, and stroke. Conclusion: Off-pump CABG compared to on-pump CABG is associated with similar short-, mid-, and long-term mortality, comparable organ protection, and fewer distal anastomoses. The concerns about the safety and efficacy of off-pump CABG are not substantiated by the current best available evidence. However, the impact of learning curve on outcomes remains a valid issue. Keywords: cardiopulmonary bypass, coronary artery bypass grafting, off-pump coronary artery bypass grafting, on-pump coronary artery bypass grafting, meta-analysis
Content may be subject to copyright.
© 2015 Raja. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on
how to request permission may be found at: http://www.dovepress.com/permissions.php
Comparative Effectiveness Research 2015:5 73–79
Comparative Effectiveness Research Dovepress
submit your manuscript | www.dovepress.com
Dovepress 73
REVIEW
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/CER.S62637
Off-pump versus on-pump coronary artery bypass
grafting: comparative effectiveness
Shahzad G Raja
Department of Cardiac Surgery,
Harefield Hospital, London, UK
Correspondence: Shahzad G Raja
Department of Cardiac Surgery,
Hareeld Hospital, Hill End Road,
Hareeld, Middlesex UB96JH, UK
Tel +44 18 9582 6511
Fax +44 18 9582 8992
Email drrajashahzad@hotmail.com
Background: Historically, coronary artery bypass grafting (CABG) with the use of cardio-
pulmonary bypass (CPB), referred to as on-pump CABG, has been regarded as the “gold
standard”. However, in recent years, it has been increasingly recognized that the systemic
inflammatory response associated with using CPB contributes substantially to postoperative
organ dysfunction. Intuitively, performance of CABG without CPB, referred to as off-pump
CABG, should translate into improved clinical outcomes. Interestingly, no single randomized
trial has been able to prove the superiority of off-pump CABG over on-pump CABG for all hard
outcomes, and off-pump CABG remains the subject of intense scrutiny as well as controversy.
The purpose of the review is to summarize the current best available evidence, comparing the
effectiveness of off- and on-pump CABG.
Methods: The English language scientific literature was reviewed primarily by searching
MEDLINE from January 2010 to December 2014 using PubMed interface to identify meta-
analyses and systematic reviews of randomized controlled trials as well as observational studies
using propensity score matching, comparing the effectiveness of off- and on-pump CABG.
Results: Current best available evidence from meta-analyses and systematic reviews of
randomized controlled trials as well as propensity score analyses suggests that off-pump CABG
is associated with fewer distal anastomoses, increased repeat revascularization rates, and poor
saphenous vein graft patency compared with on-pump CABG. No significant differences were
observed for other hard outcomes including mortality, myocardial infarction, and stroke.
Conclusion: Off-pump CABG compared to on-pump CABG is associated with similar short-,
mid-, and long-term mortality, comparable organ protection, and fewer distal anastomoses.
The concerns about the safety and efficacy of off-pump CABG are not substantiated by the
current best available evidence. However, the impact of learning curve on outcomes remains
a valid issue.
Keywords: cardiopulmonary bypass, coronary artery bypass grafting, off-pump coronary artery
bypass grafting, on-pump coronary artery bypass grafting, meta-analysis
Introduction
Coronary artery bypass grafting (CABG) remains the preferred treatment in patients
with complex coronary artery disease in the current era of tremendous upsurge in the
use of percutaneous interventions for the treatment of symptomatic coronary artery
disease. Traditionally, CABG has been performed with the aid of cardiopulmonary
bypass (CPB), enabling the construction of coronary anastomoses on a still heart in a
bloodless field.1 This on-pump CABG technique has remained the gold standard with
which all other surgical revascularization methods have been compared. However, con-
ventional on-pump CABG, despite its well-recognized safety and efficacy, is associated
Number of times this article has been viewed
This article was published in the following Dove Press journal:
Comparative Effectiveness Research
4 November 2015
Comparative Effectiveness Research 2015:5
submit your manuscript | www.dovepress.com
Dovepress
Dovepress
74
Raja
with a profound systemic inflammatory response secondary
to the use of CPB. This systemic inflammatory response to
CPB has the potential of causing myocardial ischemic injury,
neurocognitive deficits, strokes, as well as pulmonary, renal,
and hematologic complications.2
A rational way of counteracting the effects of this inflam-
matory response may be the avoidance of CPB itself. This
idea provided the catalyst for rejuvenation of off-pump
CABG a technique that predates CPB but was rapidly
replaced by on-pump CABG soon after the invention of
the extracorporeal circulation.1 The initial enthusiasm that
off-pump CABG will result in superior outcomes has been
recently met with growing concern that it is associated with
incomplete revascularization, suboptimal graft patency, and
worse long-term survival compared with conventional on-
pump CABG.3 These concerns have fueled a lot of skepticism
about the place of off-pump CABG as a recognized treatment
option for coronary artery disease. The only means of
countering this skepticism is by comparing the effectiveness
of off- and on-pump CABG through the explicit and consci-
entious assessment of current best available evidence.
A logical and comprehensive approach to evaluating
clinically relevant research incorporates many different types
of evidence (including randomized controlled trials [RCTs],
nonrandomized controlled trials, and experimental data) and
analyzes the informations content for consistency, coherence,
and clarity.4 It has long been recognized that not all research
designs are equal in terms of the risk of error and bias in
their results. When seeking answers to specific questions,
some research methods provide better evidence than that
provided by other methods. That is, the validity of the results
of research varies as a consequence of the different methods
used. For example, when evaluating the effectiveness of an
intervention, the RCT is considered to provide the most reli-
able evidence.5 It is considered the most reliable evidence
because the processes used during the conduct of an RCT
minimize the risk of confounding factors influencing the
results. As a result of this, the findings generated by RCTs
are likely to be closer to the true effect than that generated
by other research methods.5 However, the conduct of RCTs
is costly and often inefficient due to the large number of
participants needed to estimate the treatment effects with
adequate precision.6 Furthermore, conducting RCTs may
not be feasible or even ethical for all clinical questions of
interest, and restrictive selection criteria can limit the external
validity of their results.7
Observational studies are often a practical alternative to
efficiently obtain estimates of the effectiveness of treatment
in nonexperimental, routine-care settings. Nonetheless,
the lack of randomization and other RCT design elements
renders observational studies susceptible to biases, includ-
ing confounding (and particularly confounding by factors
that affect treatment choice and are also causally associated
with the outcome), selection, and differential ascertain-
ment bias.8 Proposed as a potential solution to the problem
of confounding of the treatment–outcome association, a
propensity score expresses the probability of having been
treated with an intervention based on variables measured at
or before the time of treatment.9,10 Analyses using propensity
score methods attempt to emulate randomized comparisons,
because they allow contrasts between patient groups that are
on average similar on all observed confounders.
A rational approach to comparing the effectiveness of
two treatment strategies will be to take into consideration
evidence from RCTs as well as propensity score-matched
observational studies. In recent years, with the increasing
popularity of systematic reviews, these are starting to replace
the RCT as the best source of evidence.5 This review article
attempts to assess the comparative effectiveness of off- and
on-pump CABG by evaluating the current best available
evidence from most up-to-date systematic reviews and
meta-analyses of RCTs as well as propensity score-matched
observational studies.
Methods
Search methodology
The English language scientific literature was only reviewed
primarily by searching MEDLINE from January 2010 to
December 2014 using PubMed interface.11 Keywords used
in the search included MeSH terms: meta-analysis, CPB,
extracorporeal circulation, coronary artery bypass surgery,
CABG, and off-pump coronary artery bypass. In addition,
non-MeSH terms such as systematic review, CABG, on-pump
coronary artery bypass surgery, OPCAB, off-pump coronary
artery bypass surgery, and beating heart coronary artery
surgery were also used. The “related articles” function was
used to broaden the search, and all abstracts, studies, and cita-
tions scanned were reviewed. The reference lists of articles
found through these searches were also reviewed for relevant
articles. In addition, links on Web sites (e-library, CINAHL
[Cumulative Index to Nursing and Allied Health Literature],
DARE [Database of Abstracts of Reviews of Effectiveness],
and EMBASE) containing published articles were searched
for relevant information. The author of this article chose
systematic reviews and meta-analysis of RCTs only relevant
to the topic. The search was done in stages so as to achieve
Comparative Effectiveness Research 2015:5 submit your manuscript | www.dovepress.com
Dovepress
Dovepress
75
Off-pump versus on-pump CABG
the search strategy with a high sensitivity (meaning that it
has the highest likelihood of retrieving all relevant articles).
Similar search terms were combined using the Boolean
operator “OR” tond all abstracts that contained information
about a particular search term. These individual terms were
then combined using the Boolean operator “AND” to find
articles that contained information on all the search terms.
This is a well-recognized method for performing sensitive
searches and has been described in detail in the British
Medical Journal.12
Inclusion criteria
All meta-analyses or systematic reviews of blinded or
unblinded RCTs as well as propensity score-matched
observational studies comparing off-pump CABG on the
beating heart with conventional on-pump CABG on CPB
using cardioplegic arrest, recruiting adult human patients
undergoing multivessel bypass grafting, and reporting
impact of these two techniques on any clinical outcome
published between January 2010 and December 2014 were
included. Meta-analyses reporting on the outcomes of
hybrid revascularization procedures, robotically assisted
surgery, using circulatory assist devices, or comparing
off-pump CABG with drug-eluting stents were excluded.
The rationale for including meta-analyses or systematic
reviews published from January 2010 onward was only to
ensure that the meta-analyses included ROOBY, DOORS,
CORONARY, and GOPCABE trials, the four large multi-
institutional trials that first reported the outcomes in 2009,
2012, and 2013.13–16
Data extraction and validation of the
studies
The articles found by the search strategy (Figure 1) were then
appraised. The appraisal of each article was performed in a
structured format, using critical appraisal checklists. These
are widely available in several formats and aid in assessing
the article for methodological and analytical soundness and
help uncover any significant methodological flaws.17 The
following information was extracted from each study: first
author, year of publication, included studies, number of
patients operated on with each technique, and key outcomes
(Table 1).
Results
Evidence from meta-analysis of RCTs
In-hospital mortality
Sá et al18 published a meta-analysis of 47 RCTs including
a total of 13,524 patients (6,758 for off-pump and 6,766
for on-pump CABG). The in-hospital or 30-day mortality
498 Studies identified from
database(s) search 29 Studies identified through references and related
articles
Studies outside January 2010–December 2014
period (n=282)
Title or abstract not appropriate (n=120)
Narrative reviews excluded (n=58)
Systematic reviews of OS (n=36)
Systematic reviews comparing OPCAB with strategies
other than on-pump CABG (n=14)
Outdated systematic reviews (n=9)
527 Studies identified in initial
search
245 Studies identified and
screened for retrieval
125 Studies retrieved for more
detailed evaluation
Eight latest meta-analyses
deemed appropriate and included
Figure 1 Search strategy.
Abbreviations: OS, observational studies; OPCAB, off-pump coronary artery bypass; CABG, coronary artery bypass grafting.
Comparative Effectiveness Research 2015:5
submit your manuscript | www.dovepress.com
Dovepress
Dovepress
76
Raja
showed no statistical significant difference between off-
pump CABG compared to on-pump CABG (random-effect
model: risk ratio [RR] 0.938, 95% confidence interval [CI]
0.731–1.203, P=0.612).
Mid-term mortality
Chaudhry et al19 in their recently published meta-analysis
reported that off-pump CABG confers similar overall mid-
term survival when compared with on-pump CABG (hazard
ratio [HR] 1.06, 95% CI 0.95–1.19, P=0.31). Zhang et al20
also confirmed that off-pump CABG does not increase 1-year
mortality compared to on-pump CABG.
Mid-term major cardio- and cerebrovascular events
Takagi et al published a meta-analysis of eight large RCTs
including 10,954 patients randomized to off-pump or on-
pump CABG. A pooled analysis demonstrated no statisti-
cally significant difference in off- and on-pump CABG in
the random-effects model for mid-term major cardio- and
cerebrovascular events (HR 1.10, 95% CI 0.93–1.29, P for
effect =0.27; P for heterogeneity =0.03).21
Graft patency
Zhang et al22 reported an increased risk of occlusion of all
grafts (RR 1.35, 95% CI 1.16–1.57) and saphenous vein grafts
(SVGs) (RR 1.41, 95% CI 1.24–1.60) in the off-pump CABG
group, whereas there was no significant difference in graft
occlusion of left internal mammary artery (RR 1.15, 95% CI
0.83–1.59) and radial artery (RR 1.37, 95% CI 0.76–2.47)
grafts between off- and on-pump CABG.22 This was a meta-
analysis of 12 RCTs, for a total of 3,894 and 4,137 grafts
performed during off- and on-pump CABG, respectively.
Repeat revascularization
Takagi et al23 published a meta-analysis to determine whether
repeat revascularization rates are increased following
off-pump CABG. Pooled analysis of 12 RCTs demonstrated a
statistically significant 38% increase in repeat revasculariza-
tion rates with off-pump relative to on-pump CABG in the
fixed-effects model (odds ratio [OR] 1.38, 95% CI 1.09–1.76,
P=0.008) at $1 year. In general, exclusion of any single
trial from the analysis did not substantively alter the overall
result of this analysis. There was no evidence of significant
publication bias.
Long-term survival
The most recently published pooled analysis of five RCTs
(1,486 patients) demonstrated a statistically nonsignifi-
cant 14% increase in mortality at $5 years with off-pump
relative to on-pump CABG (HR 1.14, 95% CI 0.84–1.56,
P=0.39).24
Evidence from meta-analysis of propensity
score-matched observational studies
Kuss et al25 published a systematic review and meta-analysis
of 35 propensity score analyses accounting for a total of
123,137 patients. The estimated overall OR was ,1 for
all outcomes, favoring off-pump surgery. This benefit was
statistically significant for mortality (OR 0.69; 95% CI
0.60–0.75), stroke, renal failure, red blood cell transfusion
(P,0.0001), wound infection (P,0.001), prolonged ventila-
tion (P,0.01), inotropic support (P=0.02), and intra-aortic
balloon pump support (P=0.05). The OR for myocardial
infarction, atrial fibrillation, and reoperation for bleeding
were not significant.
Table 1 Current best available evidence (meta-analyses of RCTs) comparing off-pump and on-pump coronary artery bypass grafting
Author (ref) Year No of RCTs Total patients No OPCAB No CPB Key outcome
Sá et al18 2012 47 13,524 6,758 6,766 Similar 30-day mortality; similar MI; 20.7%
reduction in stroke after OPCAB
Chaudhry et al19 2014 5 1,486 744 742 Similar mid-term survival
Takagi et al21 2014 8 10,954 5,481 5,473 Similar mid-term MACCE
Zhang et al22 2014 12 8,031* 3,894* 4,137* Reduced SVG patency after OPCAB;
similar LIMA and RA patency
Takagi et al23 2013 12 11,594 5,811 5,783 38% increase in RR rates after
off-pump CABG
Takagi et al24 2014 5 1,486 744 742 Statistically nonsignicant 14% increase in
long-term mortality after off-pump CABG
Note: *No of grafts analyzed (no of patients 11,594).
Abbreviations: CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass (on-pump); LIMA, left internal mammary artery; MACCE, major adverse
cardiovascular and cerebrovascular events; MI, myocardial infarction; OPCAB, off-pump coronary artery bypass; RA, radial artery; RCT, randomized controlled trial;
RR, repeat revascularization; SVG, saphenous vein graft; No, number.
Comparative Effectiveness Research 2015:5 submit your manuscript | www.dovepress.com
Dovepress
Dovepress
77
Off-pump versus on-pump CABG
Discussion
Current best available evidence in the form of meta-analyses
and systematic reviews of RCTs as well as propensity score-
matched studies confirms comparable impact of off- and
on-pump CABG on short-, mid-, and long-term mortality as
well as major cardio- and cerebrovascular events with fewer
distal anastomoses, poor SVG patency, and increased repeat
revascularization rates after off-pump CABG.18–25
Since its renaissance nearly 2 decades ago, off-pump
CABG has remained a subject of intense scrutiny. It has
been compared with the gold standard on-pump CABG in
numerous RCTs as well as large retrospective observational
studies.26 However, inability of small, prospective, RCTs that
have lacked sufficient sample size to demonstrate differences
in early and long-term outcomes coupled with mispercep-
tions and misconceptions about incomplete revascularization,
reduced long-term graft patency, and increased need for repeat
revascularization resulting in inferior long-term survival have
prompted opponents of off-pump CABG to demand abandon-
ment of this technique.3 On the other hand, proponents of
off-pump CABG claim that larger observational studies that
are better powered to statistically compare outcomes have
shown more favorable in-hospital outcomes and equivalent
long-term outcomes with off- and on-pump CABG.26
In the current era of evidence-based medicine, the logical
approach to comparing the effectiveness of two therapeutic
strategies, ie, off- and on-pump CABG, is to evaluate the
best available evidence. At present, evidence from systematic
reviews and meta-analysis is regarded as the gold standard.5
This comparative effectiveness review of off- and on-pump
CABG evaluated the current best available evidence and
found comparable effectiveness of off- and on-pump CABG
for hard outcomes.
Fewer distal anastomoses coupled with poor SVG pat-
ency are well-recognized criticisms of off-pump and also
reported by the current best available evidence.3,22 Incomplete
revascularization and poor graft patency translate into
increased repeat revascularization and are associated with
worse long-term survival.24 Grafting of vessels on the lat-
eral and inferior aspects is no longer impossible due to the
availability of modern stabilizers, heart positioning devices,
and intracoronary shunts. Hence, it is imperative that any
future RCTs reporting incomplete revascularization after
off- and on-pump CABG must provide an explanation for
failure to completely revascularize.26 Moreover, the future
trials comparing the effectiveness of off- and on-pump
CABG must include a myocardium at risk score, which is
a potentially valuable tool to aid in determining the true
significance of the non-revascularized territory, because
there is a recognized hierarchy of effect, depending on
which vessels are left ungrafted and how much myocardium
is at risk.27 Furthermore, it is equally important to understand
that completeness of revascularization and number of grafts
should not be used synonymously. In many centers, off-pump
CABG is offered to patients who only require one or two
grafts, whereas, all else equal, the same patient requiring four
or five grafts will not be considered for off-pump CABG.
A more logical way to address the issue of completeness
of revascularization is to use the index of completeness of
revascularization (number of grafts performed divided by the
number of grafts needed [number of graftable vessels with
angiographically significant stenoses]).26
Tangentially mentioned is the fact that some patients
are selected for off-pump CABG because of their high risk
status and these patients are intentionally offered incomplete
revascularization as a “lesser of two evils” or “perfection is
the enemy of good” strategy.
Similarly, any RCT comparing graft patency after off-
and on-pump CABG must provide information about the
mode of conduit harvesting as well as the experience of
conduit harvester and principal operator, important but often
unrecognized confounders. Interestingly, all concerns about
suboptimal graft patency in recent years have been predomi-
nantly attributed to ROOBY trial.13 This trial demonstrated
that the patency rate of the off-pump arm was lower than
that of the on-pump arm on 12-month angiography, and the
1-year composite adverse outcome rate (death from any
cause, nonfatal myocardial infarction, and any reintervention
procedure) was higher for off-pump than that for on-pump
CABG. Such findings can be explained on the basis that the
53 participating surgeons enrolled on average only eight
patients per year during the study period and had unaccept-
ably high conversion rates to on-pump surgery (12%) and
incomplete revascularization (18%). Moreover, in 60% of
the cases, a resident was the primary surgeon again raising
concerns about the relative inexperience translating into
poor graft patency. Another unrecognized confounder that
contributed to poor graft patency in the ROOBY trial was
the concomitant use of endoscopic vein harvesting (EVH)
in 1,471 patients (on-pump =907 and off-pump =564).13 The
incidence of a patient having one or more occluded SVGs
on follow-up angiography was 41.3% in the EVH group,
compared with 28.0% in the open vein harvesting group
(P,0.0001). Overall, SVG patency in the EVH group was
Comparative Effectiveness Research 2015:5
submit your manuscript | www.dovepress.com
Dovepress
Dovepress
78
Raja
74.5%, which was significantly worse than the 85.2% rate in
the open vein harvesting group (P,0.0001).28 Since ROOBY
trial was recruiting at a time when EVH was not being widely
practiced, the poor vein graft patency secondary to EVH can
be attributed to learning curve and relative inexperience of the
vein harvesters. Poor conduit quality, a consequence of the
learning curve for EVH, has been shown to be a predictor of
early graft failure, blunted positive remodeling, and greater
negative remodeling.29
The unique technical challenges of off-pump CABG fuel
the perception that adoption of this myocardial revascular-
ization strategy may lead to poorer outcomes during each
surgeon’s “learning curve”.30 Interestingly, those who perceive
off-pump CABG as an inferior revascularization strategy
with a steep learning curve propose it as a preferred option
for high-risk patients.3 There is no doubt that despite the
substantial learning curve associated with off-pump CABG,
early outcomes of off-pump CABG in high-risk patients
are better than those of conventional on-pump CABG.31
However, these superior outcomes in high-risk patients can
only be achieved if off-pump is offered to high- and low-
risk patients alike. In the current era, increasing number of
patients with high-risk profile is being referred for CABG.
In view of changing the patients’ profile, it will be prudent to
acknowledge that off-pump CABG is a valuable technique in
the armamentarium of cardiac surgeons and is here to stay.26
This further emphasizes the need for recognition of off-pump
CABG as a subspecialty with structured training program
to ensure that myocardial revascularization surgeons of the
future can negotiate the learning curve for off-pump safely
and perform CABG for high-risk patients as proficiently as
for low-risk patients. There is ample evidence to validate
that the learning curve in off-pump CABG can be safely
negotiated with appropriate patient selection, individual-
ized grafting strategy, peer-to-peer training of the entire
team, and graded clinical experience (preoperative planning,
adequate exposure, proximal anastomoses to the aorta, and
distal anastomoses initially to anterior wall vessels, followed
by inferior wall vessels and then lateral wall vessels).32 In
fact, centers with established off-pump training programs
have consistently shown that off-pump CABG can be safely
and successfully taught to trainees without jeopardizing
outcomes.33,34
Currently, off- and on-pump CABG have comparable
outcomes. The concerns about the safety and efficacy of
off-pump CABG are not substantiated by the current best
available evidence. However, the impact of learning curve
on outcomes remains a valid issue.
Disclosure
The author reports no conflicts of interest in this work.
References
1. Raja SG, Berg GA. Impact of off-pump coronary artery bypass surgery
on systemic inflammation: current best available evidence. J Card Surg.
2007;22(5):445–455.
2. Landis C. Why the inflammatory response is important to the cardiac
surgical patient. J Extra Corpor Technol. 2007;39(4):281–284.
3. Lazar HL. Should off-pump coronary artery bypass grafting be
abandoned? Circulation. 2013;128(4):406–413.
4. Mack MJ, Duhaylongsod FG. Through the open door! Where has the
ride taken us? J Thorac Cardiovasc Surg. 2002;124(4):655–659.
5. Evans D. Hierarchy of evidence: a framework for ranking evidence
evaluating healthcare interventions. J Clin Nurs. 2003;12(1):77–84.
6. Kent DM, Trikalinos TA. Therapeutic innovations, diminishing returns,
and control rate preservation. JAMA. 2009;302(2):2254–2256.
7. Dahabreh IJ, Sheldrick RC, Paulus JK, et al. Do observational
studies using propensity score methods agree with randomized trials?
A systematic comparison of studies on acute coronary syndromes. Eur
Heart J. 2012;33(15):1893–1901.
8. Byar DP. Why databases should not replace randomized clinical trials.
Biometrics. 1980;36(2):337–342.
9. Rosenbaum PR, Rubin DB. The central role of the propensity score in
observational studies for causal effects. Biometrika. 1983;70(1):41–55.
10. Rubin DB. The design versus the analysis of observational studies for
causal effects: parallels with the design of randomized trials. Stat Med.
2007;26(1):20–36.
11. Tomasulo P. The NLM Gateway: something old, something new. Med
Ref Serv Q. 2004;23(1):41–49.
12. Greenhalgh T. How to read a paper. The medline database. BMJ. 1997;
315(7101):180–183.
13. Shroyer AL, Grover FL, Hattler B, et al; Veterans Affairs Random-
ized On/Off Bypass (ROOBY) Study Group. On-pump versus off-
pump coronary-artery bypass surgery. N Engl J Med. 2009;361(19):
1827–1837.
14. Lamy A, Devereaux PJ, Prabhakaran D, et al; CORONARY
Investigators. Off-pump or on-pump coronary-artery bypass grafting
at 30 days. N Engl J Med. 2012;366(16):1489–1497.
15. Houlind K, Kjeldsen BJ, Madsen SN, et al; DOORS Study Group.
On-pump versus off-pump coronary artery bypass surgery in elderly
patients: results from the Danish on-pump versus off-pump randomiza-
tion study. Circulation. 2012;125(20):2431–2439.
16. Diegeler A, Börgermann J, Kappert U, et al; GOPCABE Study Group.
Off-pump versus on-pump coronary-artery bypass grafting in elderly
patients. N Engl J Med. 2013;368(13):1189–1198.
17. Mackway-Jones K, Carley CD, Morton RJ. Best BETs Critical Appraisal
Worksheets. 2015. Available from: http://www.bestbets.org/links/BET-
CA-worksheets.php. Accessed April 7, 2015.
18. Sá MP, Ferraz PE, Escobar RR, et al. Off-pump versus on-pump coro-
nary artery bypass surgery: meta-analysis and meta-regression of 13,524
patients from randomized trials. Rev Bras Cir Cardiovasc. 2012;27(4):
631–641.
19. Chaudhry UA, Harling L, Rao C, et al. Off-pump versus on-pump coro-
nary revascularization: meta-analysis of mid- and long-term outcomes.
Ann Thorac Surg. 2014;98(2):563–572.
20. Zhang B, Zhou J, Li H, Zhou M, Chen A, Zhao Q. Off-pump coronary
artery bypass grafting does not increase the 1-year mortality compared to
on-pump: a meta-analysis of randomized controlled trials. Int J Cardiol.
2013;169(5):e93–e95.
21. Takagi H, Watanabe T, Mizuno Y, Kawai N, Umemoto T; ALICE (All-
Literature Investigation of Cardiovascular Evidence) Group. A meta-
analysis of large randomized trials for mid-term major cardio- and
cerebrovascular events following off-pump versus on-pump coronary artery
bypass grafting. Interact Cardiovasc Thorac Surg. 2014;18(4):522–524.
Comparative Effectiveness Research
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/comparative-effectiveness-research-journal
Comparative Effectiveness Research is an international, peer reviewed
open access journal focusing on comparative effectiveness of health
care including preventative health care strategies, diagnostic strategies,
diagnostic technology, medical devices, drugs, medical technology,
health systems and organization. The manuscript management system
is completely online and includes a very quick and fair peer-review
system. Visit http://www.dovepress.com/testimonials.php to read real
quotes from published authors.
Comparative Effectiveness Research 2015:5 submit your manuscript | www.dovepress.com
Dovepress
Dovepress
Dovepress
79
Off-pump versus on-pump CABG
22. Zhang B, Zhou J, Li H, Liu Z, Chen A, Zhao Q. Comparison of graft
patency between off-pump and on-pump coronary artery bypass grafting:
an updated meta-analysis. Ann Thorac Surg. 2014;97(4):1335–1341.
23. Takagi H, Mizuno Y, Niwa M, Goto SN, Umemoto T; ALICE (All-
Literature Investigation of Cardiovascular Evidence) Group. A meta-
analysis of randomized trials for repeat revascularization following
off-pump versus on-pump coronary artery bypass grafting. Interact
Cardiovasc Thorac Surg. 2013;17(5):878–880.
24. Takagi H, Umemoto T; All-Literature Investigation of Cardiovascular
Evidence (ALICE) Group. Worse long-term survival after off-pump than
on-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg.
2014;148(5):1820–1829.
25. Kuss O, von Salviati B, Börgermann J. Off-pump versus on-pump
coronary artery bypass grafting: a systematic review and meta-analysis
of propensityscore analyses. J Thorac Cardiovasc Surg. 2010;140(4):
829–835.
26. Raja SG, Benedetto U. Off-pump coronary artery bypass grafting:
misperceptions and misconceptions. World J Methodol. 2014;4(1):6–10.
27. Robertson MW, Buth KJ, Stewart KM, et al. Complete revascularization
is compromised in off-pump coronary artery bypass grafting. J Thorac
Cardiovasc Surg. 2013;145(4):992–998.
28. Zenati MA, Shroyer AL, Collins JF, et al. Impact of endoscopic versus
open saphenous vein harvest technique on late coronary artery bypass
grafting patient outcomes in the ROOBY (Randomized On/Off Bypass)
trial. J Thorac Cardiovasc Surg. 2011;141(2):338–344.
29. Raja SG, Sarang Z. Endoscopic vein harvesting: technique, out-
comes, concerns and controversies. J Thorac Dis. 2013;5(Suppl 6):
S630–S637.
30. Song HK, Petersen RJ, Sharoni E, Guyton RA, Puskas JD. Safe
evolution towards routine off-pump coronary artery bypass: negotiating
the learning curve. Eur J Cardiothorac Surg. 2003;24(6):947–952.
31. Stamou SC, Corso PJ. Coronary revascularization without cardiopul-
monary bypass in high-risk patients: a route to the future. Ann Thorac
Surg. 2001;71(3):1056–1061.
32. Halkos ME, Puskas JD. Teaching off-pump coronary artery bypass
surgery. Semin Thorac Cardiovasc Surg. 2009;21(3):224–228.
33. Murzi M, Caputo M, Aresu G, Duggan S, Angelini GD. Training
residents in off-pump coronary artery bypass surgery: a 14-year
experience. J Thorac Cardiovasc Surg. 2012;143(6):1247–1253.
34. Bakaeen FG, Sethi G, Wagner TH, et al. Coronary artery bypass
graft patency: residents versus attending surgeons. Ann Thorac Surg.
2012;94(2):482–488.
... Но это хирургическое вмешательство у пациентов с тяжелым коморбидным фоном [в частности, с сахарным диабетом (СД)] сопряжено со значительными послеоперационными рисками. Большинство исследователей относят СД к независимому фактору риска развития «больших» (смерть, инфаркт миокарда, инсульт, необходимость повторной реваскуляризации) послеоперационных осложнений [4][5][6]. ...
... Но данная тактика нередко не приносит желаемого результата у пациентов с СД из-за дисфункции органов и систем организма на фоне распространенного атеросклероза и часто многососудистого эшелонированного поражения коронарных артерий [9]. Поэтому поиск методов снижения частоты развития послеоперационных осложнений после off-pump КШ у пациентов данной категории не потерял своей актуальности [4,5,10]. ...
... Существенная роль в решении вопросов профилактики отводится определению врачом анестезиологом-реаниматологом объема и качества анестезиологического пособия, медикаментозной поддержки, инфузионно-трансфузионной терапии [1,2]. Приходится решать проблему модуляции выраженного операционного стрессответа со значительными эндокринно-метаболическими, системными воспалительными, гемодинамическими, коагулопатическими и другими нарушениями [5,7]. ...
Article
Full-text available
Diabetes mellitus is an independent risk factor for the development of early postoperative complications in coronary artery bypass grafting without cardiopulmonary bypass (off-pump CABG). A comparative analysis of early postoperative complications for off-pump CABG in patients with diabetes mellitus was made. A randomized study of the results of surgical treatment of patients with coronary heart disease who underwent coronary artery bypass grafting of 2 or more branches of the coronary arteries without the use of cardiopulmonary bypass included 191 patients. In patients of the main group (n = 32), the comorbid background was complicated by diabetes; in patients in the control group (n = 159), this disease was not detected. For statistical processing of the obtained data, nonparametric criteria were used (Fisher test and relative risk (RR) with a 95% confidence interval (CI)). It is proved that in patients of the main group (with diabetes) the relative risk of developing postoperative complications (acute myocardial infarction, pneumonia, acute renal failure, multiple organ failure syndrome, etc.) is significantly higher than in patients in the control group (RR = 1.36–4.97). The use of combined anesthesia (with prolonged thoracic epidural analgesia) allowed patients of both groups to significantly reduce the risk of developing clinically significant complications (RR = 0.26–0.78). Performing off-pump CABG in patients with diabetes is associated with a significant increase in the risk of postoperative complications, and the use of combined anesthesia effectively reduces the risk of their development in patients of this category.
... Коронарное шунтирование (КШ), с использованием искусственного кровообращения (ИК) и без него, до настоящего времени является одним из наиболее часто применяемых методов хирургического лечения больных ишемической болезнью сердца (ИБС) с многососудистым поражением коронарных артерий [3,4,9,15,16,18]. ...
... Существенная роль в решении вопросов профилактики отводится определению врачом анестезиологом-реаниматологом объема и качества анестезиологического пособия, медикаментозной поддержки, инфузионно-трансфузионной терапии [9,18]. Приходится решать проблему модуляции выраженного операционного стресс-ответа со значительными эндокринно-метаболическими, системными воспалительными, гемодинамическими, коагулопатическими и другими нарушениями [1,2,5,6,7,10,11,12,13,15,16]. ...
... Некоторые авторы отмечают положительную роль грудной эпидуральной анестезии (ГЭА) в снижении операционного стресс-ответа и риска развития целого ряда осложнений (острого послеоперационного панкреатита (ОПП), абдоминального компартмент-синдрома (АКС), синдрома системного воспалительного ответа (ССВО), ОИМ и др.), нередко сопровождающих, в том числе, и коронарное шунтирование [3,9,15,16]. ...
... Though data on mortality in still controversial (4)(5)(6)(7). The present study is an effort to investigate the distribution of different risk factors, angiographic patterns and short-term mortality in patients undergoing on -pump CABG and off-pump CABG groups and compare short-term outcomes among different subgroups of patients with coronary artery disease. ...
... Our present data on mortality is in accordance with Kowalewski et al. (4) and Giovanni et al. (5) studies. However, Raja et al. (6) and Daniel et al. (7) studies did not find significant differences in short-term mortality between on -pump and offpump CABG patients. The short-term mortality in our study, was the highest among age group of 50-69 years in on -pump CABG patients and among 50 to 59 years for off -pump CABG in the present study. ...
... But the our present data correlates with kowalewski et al 2020 (4) Study and Giovanni et al 2017 (5) . But Raja et al 2015 (6) , Daniel et al 2016 (7) , studies doesn't correlate with the present study as these studies finds no significant difference in short term mortality between on pump and off pump The short term mortality was highest among age group of 50-69 years on patients undergone on pump cabg and 50 to 59 years for off pump cabg this is against to that of Nicolini et al 2017 (8) which shows highest mortality among 70-89 years followed by 60 to 69 years which can explained as less number of patients above 70 years have undergone procedure in present study The short term mortality was highest among on pump group patients with Ef less than 40 than off pump group correlating with Zhiyuan et al (9) it was found in this study that the left main involvement in multivessel disease had some contribution to the mortality more in on pump group . This was against with Benedetto et al 2019 (11) study and supported by yeatman et al 2001 (10) ...
Article
Background: The main aim of the study is to investigate the prevelance of different risk factors, angiographic patterns undergoing cabg , the within 30 day mortality among cabg groups with left main coronary artery disease incidences and correlating them between on pump cabg group and off pump cabg group Methods: The present study is a retrospective cross sectional observational study with data from may 2016 to December 2021 undertaken in government general hospital Kurnool. The data considered includes the age, risk factors, echo reports, angiographic data, surgery details and post surgery status. Out of 108 CABG procedures done a total of 20 patients with LM disease where taken of which 10 on pump cabg group patients and 10 off pump cabg group patients where present eligible as per inclusion criteria and exclusion criteria
... The only way to combat this skepticism is to compare the effectiveness of off-pump and on-pump CABG through an explicit and rigorous assessment of the best available evidence. 6 Previous studies comparing off-pump CABG with on-pump surgery did not show a significant difference in terms of length of intensive stay and incidence of postoperative mortality. Several studies have questioned the advantages of off-pump over on-pump surgery with some showing better outcomes and better survival expectations. ...
... A good example is a study comparing outcomes from coronary artery bypass surgeries performed both with and without pumps. 16 This study concluded that outcomes from both were comparable. The journal that published this study in 2017 stopped publishing in September 2018. ...
... In Raja's study, off-pump CABG versus on-pump CABG is correlated with comparable short-, mid-, and long-term mortality, similar organ protection, and fewer distal anastomoses. The available evidence cannot, nonetheless, substantiate all concerns about the safety and efficacy of off-pump CABG [37]. ...
Article
Full-text available
Background Coronary artery disease (CAD) is a major public health issue and a leading cause of death globally. It is one of the most common indications for surgical intervention. There are a lot of different techniques, including CABG, which consists of two approaches: sternotomy and mini-thoracotomy. Different techniques have been developed to improve surgical outcomes, including the use of machine for extracorporal circulation (on-pump) or without it (off-pump). Objective The objective of this study was to assess whether off-pump CABG offers superior short-term outcomes compared to traditional on-pump CABG in patients undergoing isolated CABG.. Methods In period between 2022 – 2023, we performed CABG operation in 80 patients. CABG was performed either on- pump or off-pump. Results The results have shown advantages and disadvantages of one or another type of CABG. We were comparing the duration of surgical procedure, time on mechanical ventilation, drainage volume, neurological incidents, time to discharge, indication for repeat revascularization and mortality between two groups. Conclusion The choice of surgical technique should be based on individual patient factors, including comorbidities and surgical risks. It is important to say that OPCABG is more challenging than ONCABG, and it is very important that OPCABG is done by skilled, experienced and confident surgeon, which contributes to better outcome and survival.
Article
Full-text available
Coronary artery bypass grafting (CABG) continues to be one of the most commonly performed cardiac surgical procedures worldwide. Conventional CABG performed on cardiopulmonary bypass termed on-pump CABG is regarded as the gold standard. However, on-pump CABG results in several physiologic derangements including but not limited to thrombocytopenia, activation of complement factors, immune suppression, and inflammatory responses leading to organ dysfunction. Furthermore, manipulating an atherosclerotic ascending aorta during cannulation and cross-clamping can predispose to embolization and stroke risk. Recognition of these detrimental effects of on-pump CABG resulted in resurgence of off-pump CABG nearly two decades ago. Off-pump CABG since its resurgence has been a subject of intensive scrutiny and speculation. Despite numerous retrospective nonrandomized studies, prospective randomized trials, and meta-analyses validating the safety and efficacy of off-pump CABG, opponents of the technique have persistently demanded abandonment of off-pump CABG. Several misconceptions and misperceptions are used as an excuse for such demands. This review article examines published scientific evidence to evaluate these misperceptions and misconceptions about off-pump CABG. Keywords: Coronary artery bypass grafting, Cardiopulmonary bypass, Off-pump coronary artery bypass grafting, Surgical myocardial revascularization, Coronary artery surgery
Article
Aims: After numerous observational studies (OS) and randomized studies (RS), neither off- nor on-pump revascularization comes out superior. Patient selection and small sample size limit the compilation of clinically relevant outcomes in RS; lack of randomization limits OS. Propensity score analyses (PSA) are expected to improve on at least some of these problems. Methods: PSA on off- vs. on-pump surgery were identified from eight bibliographic data bases, citation tracking, and a free web search. Two independent reviewers abstracted data on eleven binary short-term outcomes. We used the odds ratio (OR) to describe the treatment effect. To combine ORs from different studies, the random effects inverse-variance method was applied. Results: 35 of 58 initially retrieved PSA were included, accounting for a total of 123,137 patients. The estimated odds ratio was <1 for all outcomes in favour of off-pump surgery. This was significant for mortality, stroke, renal failure, RBC transfusion (p<0.0001), wound infection (p<0.001), prolonged ventilation (p<0.01), inotropic (p=0.02) and IABP support (p=0.05). The odds ratios for myocardial infarction and atrial fibrillation remained nonsignificant. Conclusions: Like OS, but unlike RS, PSA find significant advantages for relevant outcomes with off-pump surgery. Study populations need to be compared to clarify if different results of PSA and RS are related to patient selection (limited external validity).
Article
To determine whether repeat revascularization rates are increased following off-pump coronary artery bypass grafting (CABG), we performed a meta-analysis of randomized controlled trials of off-pump vs on-pump CABG. Databases including MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials were searched through March 2013 using web-based search engines (PubMed, OVID). Studies considered for inclusion met the following criteria: the design was a prospective randomized controlled clinical trial; the study population was patients undergoing CABG; patients were randomly assigned to off-pump vs on-pump CABG and outcomes included repeat revascularization rates at ≥1 year. Our exhaustive search identified 12 prospective randomized controlled trials of off-pump vs on-pump CABG. Pooled analysis demonstrated a statistically significant 38% increase in repeat revascularization rates with off-pump relative to on-pump CABG in the fixed-effects model (odds ratio, 1.38; 95% confidence interval, 1.09–1.76; P = 0.008). In general, exclusion of any single trial from the analysis did not substantively alter the overall result of our analysis. There was no evidence of significant publication bias. The results of our analysis suggest that off-pump CABG may increase repeat revascularization rates by 38% over on-pump CABG.
Article
Objective: To determine whether off-pump coronary artery bypass grafting (CABG) is associated with worse long-term survival compared with on-pump CABG. We performed a meta-analysis of adjusted observational studies and randomized controlled trials. Methods: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched through March 2014. Eligible studies were randomized controlled trials and adjusted observational studies (in which appropriate statistical methods adjusting for confounders had been used) of off-pump versus on-pump CABG that had reported long-term (≥5-year) all-cause mortality as an outcome. Results: Of 478 potentially relevant studies screened initially, 5 randomized trials and 17 observational studies, enrolling a total of 104,306 patients, were identified and included. A pooled analysis of all 22 studies demonstrated a statistically significant 7% increase in long-term all-cause mortality with off-pump relative to on-pump CABG (hazard ratio, 1.07; 95% confidence interval, 1.03-1.11; P=.0003). Although a pooled analysis of 5 randomized trials (1486 patients) demonstrated a statistically nonsignificant 14% increase in mortality with off-pump relative to on-pump CABG (hazard ratio, 1.14; 95% confidence interval, 0.84-1.56; P=.39), another pooled analysis of 17 observational studies (102,820 patients) demonstrated a statistically significant 7% increase in mortality with off-pump relative to on-pump CABG (hazard ratio, 1.07; 95% confidence interval, 1.03-1.11; P=.0004). Conclusions: A meta-analysis of 22 studies, enrolling a total of >100,000 patients, showed that off-pump CABG is likely associated with worse long-term (≥5-year) survival compared with on-pump CABG.
Article
Background Early outcomes for off-pump coronary artery bypass grafting (OPCAB) have been extensively compared with on-pump coronary revascularization (ONCAB); however, the long-term effects of OPCAB continue to be debated. This study aims to compare the mid-term (>1year; ≤5 years) and long-term (>5 years) survival and major adverse cardiovascular and cerebrovascular events of OPCAB versus ONCAB. Methods A systematic search identified 32 studies meeting our inclusion criteria. These were analyzed using random effects modeling, with subgroup evaluation according to study type. Primary outcomes were mid- and long-term survival over a follow-up period greater than 1 year. Secondary outcomes were mid- and long-term events including repeat revascularization, myocardial infarction, angina, heart failure, and cerebrovascular accidents. Results Off-pump coronary artery bypass grafting confers similar overall mid-term survival when compared with ONCAB (hazard ratio, 1.06; 95% confidence interval, 0.95 to 1.19; p = 0.31). On-pump coronary artery bypass grafting was associated with a significant trend towards a long-term survival advantage (hazard ratio, 1.06; 95% confidence interval, 1.00 to 1.13; p = 0.05); however, this was no longer present when subgroup analysis of only randomized controlled trials, registry-based studies, and propensity-matched studies was performed. There was an increase in angina recurrence among two studies after OPCAB, but no difference was seen in 11 other studies reporting data as odds ratio. No significant differences were observed in other secondary outcomes. Conclusions This analysis demonstrates comparable mid-term mortality and mid- to long-term morbidity between OPCAB and ONCAB. On-pump coronary artery bypass grafting may be associated with improved long-term survival when all study types are analyzed; however, analysis of only randomized controlled trials and propensity-matched studies demonstrates comparable long-term mortality between OPCAB and ONCAB.
Article
To determine whether off-pump coronary artery bypass grafting (CABG) increases mid-term major adverse cardiovascular (and cerebrovascular) events MACCE over on-pump CABG, we performed a meta-analysis of exclusive large randomized controlled trials (RCTs). Databases including MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials were searched through October 2013 using Web-based search engines (PubMed and OVID). Eligible studies were RCTs of off-pump vs on-pump CABG enrolling >100 patients in each procedure and reporting MACCE at the time of >1 year follow-up. Mixed-effects meta-regression analyses were performed to determine whether the effects of off-pump CABG on MACCE were modulated by the prespecified factors. Eight RCTs enrolling 10 954 patients were identified and included. A pooled analysis demonstrated no statistically significant difference in off-pump and on-pump CABG (hazard ratio, 1.10; 95% confidence interval, 0.93-1.29; P = 0.27). In general, exclusion of any single study from the analysis did not substantially alter the overall result of our analysis. There was no evidence of significant publication bias. Meta-regression coefficients were not statistically significant for mean age, proportion of men and that of diabetes. In conclusion, off-pump CABG appears not to increase mid-term MACCE over on-pump CABG.